Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease

Apr 4

Written By Yiran Gan

2020.04.29

NC Chen, HL Chen, SH Li, YH Chang, MH Chen, NW Tsai, CC Yu, SY Yang, CH Lu and WC Lin

Front. Aging Neurosci., 28 April 2020

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology